Carregant...
The effects of Livin shRNA on the response to cisplatin in HepG2 cells
Hepatocellular carcinoma is a lethal malignancy with poor prognosis, partially due to tumor metastasis, recurrence and resistance to chemo- or radio-therapy. Cisplatin can inhibit cancer cell DNA replication, and is widely used in the clinical treatment of tumors. The present study aimed to generate...
Guardat en:
| Publicat a: | Oncol Lett |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
D.A. Spandidos
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4665138/ https://ncbi.nlm.nih.gov/pubmed/26722271 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2015.3629 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|